X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Deep Track Capital, LP reported a 6.58% stake in X4 Pharmaceuticals, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Deep Track Capital, LP reported a 6.58% stake in X4 Pharmaceuticals, Inc., 6,663,821 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 6.58%
- Shares
- 6,663,821
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 6.58% | 6,663,821 |
| Deep Track Biotechnology Master Fund, Ltd. | 5.66% | 5,737,941 |
| David Kroin | 6.58% | 6,663,821 |
| Deep Track Special Opportunities Fund, LP. | 0.91% | 925,880 |
Source
Download original · View original at SEC
Related
- X4 Pharmaceuticals, Inc.
- Deep Track Capital, LP
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 19, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Nov 16, 2026
- Schedule 13G/A · Coastlands Capital LP · Nov 13, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026